The appointment of a new CFO often signals changes in a company's financial strategy. Eric Bjerkholt's experience and expertise could potentially lead to new financial strategies at Mirum Pharmaceuticals, impacting the company's financial performance and potentially its stock price. However, the exact impact will depend on the strategies he implements and how they are received by investors.